Description
A selective, brain penetrant EP2 antagonist (KB = 2.4 nM); blocks the induced expression of inflammatory markers in microglial cells treated with butaprost; reduces neurodegeneration in a mouse model of status epilepticus; inhibits proliferation and invasion in cancer cells treated with butaprost
Formal name: (2E)-N-[2-(2-methyl-1H-indol-1-yl)ethyl]-3-(3,4,5-trimethoxyphenyl)-2-propenamide
Synonyms:
Molecular weight: 394.5
CAS: 1164462-05-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Cancer|Cell Migration & Metastasis||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Neuroscience|Neurodegenerative Disorders||Research Area|Neuroscience|Seizure Disorders